1370261-97-4

Basic information

• Product Name: PRT062607 (Hydrochloride)
• Synonyms: PRT062607 (Hydrochloride);PRT062607 (P505-15, BIIB057) HCl;2-[[(1R,2S)-2-AMinocyclohexyl]aMino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]aMino]-5-pyriMidinecarboxaMide Hydrochloride;PRT062607 (P505-15 HCL);PRT062607 HCL;2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide hydrochloride (1:1);5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, hydrochloride (1:1);2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide hydrochloride (1:1) PRT062607 (P505-15, BIIB057) HCl
• CAS NO: 1370261-97-4
• Molecular Formula: C19H24ClN9O
• Molecular Weight: 429.90656
• Product Categories: Pharmaceuticals, Intermediates & Fine Chemicals;Inhibitors
• Mol File: 1370261-97-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Solubility: ≥21.5 mg/mL in DMSO; insoluble in EtOH; ≥83.2 mg/mL in H2O with gentle warming
• CAS DataBase Reference: PRT062607 (Hydrochloride)(CAS DataBase Reference)
• NIST Chemistry Reference: PRT062607 (Hydrochloride)(1370261-97-4)
• EPA Substance Registry System: PRT062607 (Hydrochloride)(1370261-97-4)

Safety Data

• Hazardous Substances Data: 1370261-97-4(Hazardous Substances Data)

Usage

Description

PRT062607 (Hydrochloride) is a compound that serves as a novel spleen tyrosine kinase (SYK) inhibitor. It is characterized by its ability to inhibit the activity of SYK, a protein that plays a crucial role in various cellular processes, including immune response and cell signaling. By targeting SYK, PRT062607 (Hydrochloride) has the potential to modulate these processes and offer therapeutic benefits in certain medical conditions.

Uses

Used in Pharmaceutical Industry:
PRT062607 (Hydrochloride) is used as a therapeutic agent for the treatment of leukemia. Its application is based on its ability to inhibit the spleen tyrosine kinase (SYK), which is involved in the development and progression of leukemia. By targeting SYK, PRT062607 (Hydrochloride) can potentially suppress the growth of leukemia cells and improve the treatment outcomes for patients suffering from this disease.